Fas and tumor necrosis factor receptor-mediated cell death: Similarities and distinctions

Journal of Experimental Medicine

Volumn 180, Issue 2, 1994, Pages 557-567

  Clement, Marie Veronique ^a   Stamenkovic, Ivan ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL SURFACE RECEPTOR; TUMOR NECROSIS FACTOR;

ARTICLE; CELL DEATH; CELL FUNCTION; CELL FUSION; CELL INTERACTION; CELL KILLING; CELL STIMULATION; GENE EXPRESSION; HUMAN; HUMAN CELL; LIGAND BINDING; PRIORITY JOURNAL; PROTEIN SYNTHESIS;

ANTIBODIES, MONOCLONAL; ANTIGENS, CD; ANTIGENS, CD40; ANTIGENS, CD95; ANTIGENS, DIFFERENTIATION, B-LYMPHOCYTE; ANTIGENS, SURFACE; BASE SEQUENCE; CELL DEATH; DNA; HUMAN; LIGANDS; MOLECULAR SEQUENCE DATA; RECEPTORS, TUMOR NECROSIS FACTOR; RECOMBINANT FUSION PROTEINS; SIGNAL TRANSDUCTION; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 0028287963     PISSN: 00221007     EISSN: 15409538     Source Type: Journal    
DOI: 10.1084/jem.180.2.557     Document Type: Article

References (45)

1. Clarke, P.G.H. 1990. Developmental cell death: morphological diversity and multiple mechanisms. Anat. Embryol. 181:195.
2. Cohen, J. J., R.C. Duke, V.A. Fadok, and K.S. Sellins. 1992. Apoptosis and programmed cell death in immunity. Annu. Rev. Immunol. 10:267.
3. Schwartz, L.M., and B.A. Osborne. 1993. Programmed cell death, apoptosis and killer genes. Immunol. Today. 14:582.
4. Collins, M.K.L., and A.L. Rivas. 1993. The control of apoptosis in mammalian cells. TIBS (Trends Biochem. Sci.). 18:307.
5. Cohen, J. J. 1991. Programmed cell death in the immune system. Adv. Immunol. 50:55.
6. Cohen, J. J. 1989. Lymphocyte death induced by glucocorticoids. In Anti-Inflammatory Steroid Action: Basic and Clinical Aspects. R.P. Schleimer, H.N. Claman, and A. Oronsky, editors. Academic Press, Inc., San Diego. 110.
7. Smith, C.A., G.T. Williams, R. Kingston, E. J. Jenkinson, and J. J.T. Owen. 1989. Antibodies to CD3/T-cell receptor complex induce death by apoptosis in immature T cells in thymic cultures. Nature (Lond.). 337:181.
8. Shi, Y.F., R.P. Bissonnette, N. Parfrey, M. Szalay, R.T. Kubo, and D.R. Green. 1991. In vivo administration of monoclonal antibodies to the CD3 T cell receptor complex induces cell death (apoptosis) in immature thymocytes. J. Immunol. 146:3340.
9. Zychlinsky, A., L.M. Zheng, C.C. Liu, and J.D. Young. 1991. Cytolytic lymphocytes induce both apoptosis and necrosis in target cells. J. Immunol. 146:393.
10. Sellins, K.S., and J. J. Cohen. 1987. Gene induction by gamma-irradiation leads to DNA fragmentation in lymphocytes. J. Immunol. 139:3199.
11. Yamada, T.H., and H. Ohyama. 1988. Radiation-induced interphase death of rat thymocytes is internally programmed (apoptosis). Int. J. Radiat. Biol. 53:65.
12. Itoh, N., S. Yonehara, A. Ishii, M. Yonehara, S.-I. Mizushima, M. Sameshima, A. Hase, Y. Seto, and S. Nagata. 1991. Cell. 66:233.
13. Oehm, A., I. Behrmann, W. Falk, M. Pawlita, G. Maier, C. Klas, M. Li-Weber, S. Richards, J. Dhein, B.C. Trauth, et al. 1992. Purification and molecular cloning of the APO-1 cell surface antigen, a member of the tumor necrosis factor/nerve growth factor receptor superfamily. J. Biol. Chem. 267:10709.
14. Loetscher, H., Y.-C.E. Pan, H.-W. Lahm, R. Gentz, M. Brock-haus, H. Tabuchi, and W. Lesslauer. 1990. Molecular cloning and expression of the human 55 kd tumor necrosis factor receptor. Cell. 61:351.
15. Schall, T. J., M. Lewis, K. J. Roller, A. Lee, G.C. Rice, G.H.W. Wong, T. Gatanaga, G.A. Granger, R. Lentz, H. Raab, et al. 1990. Molecular cloning and expression of a receptor for human tumor necrosis factor. Cell. 61:361.
16. Nophar, Y., O. Kemper, C. Brakebusch, H. Engelmann, R. Zwang, D. Aderka, H. Holtmann, and D. Wallach. 1990. Soluble forms of tumor necrosis factor receptors (TNF-Rs). The cDNA for the type I TNG-R, cloned using amino acid sequence data of its soluble form, encodes both the cell surface and a soluble form of the receptor. EMBO (Eur. Mol. Biol. Organ.) J. 9:3269.
17. Heller, R.A., K. Song, M.A. Onasch, W.H. Fischer, D. Chang, and G.M. Ringold. 1990. Complementary DNA cloning of a receptor for tumor necrosis factor and demonstration of a shed form of the receptor. Proc Natl. Acad. Sci. USA. 87:6151.
18. Loetscher, H., M. Brockhaus, Z. Dembic, H. Gallati, R. Gentz, U. Gubler, H.-W. Lahm, A. Lustig, Y.-C.E. Pan, E.-J. Schlaeger, et al. 1992. Biochemical and molecular characterization of TNF receptors/TNF-like receptors. Two distinct human TNF receptors: purification, molecular cloning and expression. In Tumor Necrosis Factor: Structure-Function Relationship and Clinical Application. T. Osawa, and B. Bonavida, editors. Karger, Basel. 34.
19. Johnson, D., A. Lanahan, C.R. Buck, A. Sehgal, C. Morgan, E. Mercer, M. Bothwell, and M. Chao. 1986. Expression and structure of the human NGF receptor. Cell. 47:545.
20. Camerini, D., G. Walz, W.A.M. Loenen, J. Borst, and B. Seed. 1991. The T cell activation antigen CD27 is a member of the NGF/TNF receptor gene family. J. Immunol. 147:3165.
21. Stamenkovic, I., E.A. Clark, and B. Seed. 1989. A B-lympho-cyte activation molecule related to the nerve growth factor receptor and induced by cytokines in carcinomas. EMBO (Eur. Mol. Biol. Organ.) J. 8:1403.
22. Durkop, H., U. Latza, M. Hummel, F. Eitelbach, B. Seed, and H. Stein. 1992. Molecular cloning and expression of a new member of the nerve growth factor receptor family that is characteristic for Hodgkin’s disease. Cell. 68:421.
23. Kwon, B.S., and S.M. Weissman. 1989. cDNA sequences of two inducible T-cell genes. Proc Natl. Acad. Sci. USA. 86:1963.
24. Vassalli, P. 1992. The pathophysiology of tumor necrosis factors. Annu. Rev. Immunol. 10:411.
25. Tartaglia, L.A., T.M. Ayres, G.H.W. Wong, and D.V. Goeddel. 1993. A novel domain within the 55 kd TNF receptor signals cell death. Cell. 74:845.
26. Fiers, W., R. Beyaret, P. Brouckaert, E. Decoster, D. De Valck, B. Everaerdt, J. Grooten, A. Lenaerts, C. Libert, K. Schulze-Osthoff, et al. 1992. TNF-mediated cytotoxicity: mechanism and regulation. Tumor necrosis factor: mechanism of action at the molecular, cellular and in vivo level. In Tumor Necrosis Factor: Structure-Function Relationship and Clinical Application. T. Osawa, and B. Bonavida, editors. Karger, Basel. 66.
27. Tartaglia, L.A., R.F. Weber, I.S. Figari, C. Reynolds, M.A. Palladino, Jr., and D.V. Goeddel. 1991. The two different receptors for tumor necrosis factor mediate distinct cellular responses. Proc. Natl. Acad. Sci. USA. 88:9292.
28. Heller, R.A., K. Song, N. Fan, and D. J. Chang. 1992. The p70 tumor necrosis factor receptor mediates cytotoxicity. Cell. 70:47.
29. Tartaglia, L.A., M. Rothe, Y.-F. Hu, and D.V. Goeddel. 1993. Tumor necrosis factor’s cytotoxic activity is signaled by the p55 TNF receptor. Cell. 73:213.
30. Heller, R.A., K. Song, and N. Fan. 1993. Cytotoxicity by tumor necrosis factor is mediated by both p55 and p70 receptors. Cell. 73:216.
31. Ogasawara, J., R. Watanabe-Gukunaga, M. Adachi, A. Mat-suzawa, T. Kasugai, Y. Kitamura, N. Itoh, T. Suda, and S. Nagata. 1993. Lethal effect of the anti-Fas antibody in mice. Nature (Land.). 364:806.
32. Watanabe-Fukunaga, R., C.I. Brannan, N.G. Copeland, N.A. Jenkins, and S. Nagata. 1992. Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apop-tosis. Nature (Lortd.). 356:314.
33. 2+-independent T cell-mediated cytotoxicity. J. Exp. Med. 177:195.
34. Armitage, R. J., W.C. Fanslow, L. Strockbine, T.A. Sato, K.N. Clifford, B.M. Macduff, D.M. Anderson, S.D. Gimpel, T. Davis-Smith, C.R. Maliszewski, et al. 1992. Molecular and biological characterization of a murine ligand for CD40. Nature (Lond.). 357:80.
35. Hollenbaugh, D., L.S. Grosmaire, C.D. Kullas, N. J. Chalupny, S. Braesch-Andersen, RJ. Noelle, I. Stamenkovic, J.A. Ledbetter, and A. Aruffo. 1992. The human T cell antigen gp39, a member of the TNF gene family, is a ligand for the CD40 receptor: expression of a soluble form of gp39 with B cell costimulatory activity. EMBO(Eur. Mol. Biol. Organ.)J. 11:4313.
36. Aruffo, A., M. Farrington, D. Hollenbaugh, X. Li, A. Milatovich, S. Nonoyama, J. Bajorath, L.S. Grosmaire, R. Stenkamp, M. Neubauer, et al. 1993. The CD40 ligand, gp39, is defective in activated T cells from patients with X-linked hyper-IgM syndrome. Cell. 72:291.
37. Fuleihan, R., N. Ramesh, R. Loh, H. Jabara, F.S. Rosen, T. Chatila, S-M. Fu, I. Stamenkovic, and R.S. Geha. 1993. Defective expression of the CD40 ligand in X chromosome-linked immunoglobulin deficiency with normal or elevated IgM. Proc. Natl Acad. Sci. USA. 90:2170.
38. Thomas, L., H.R. Byers, J. Vink, and I. Stamenkovic. 1992. CD44H regulates tumor cell migration on hyaluronate-coated substrate. J. Cell Biol. 118:971.
39. Paulie, S., A. Rosen, B. Ehlin-Henriksson, S. Braesch-Andersen, E. Jakobson, H. Koho, and P. Perlmann. 1989. The human B lymphocyte and carcinoma antigen, CDw40, is a phos-phoprotein involved in growth signal transduction. J. Immunol. 142:590.
40. Aruffo, A., I. Stamenkovic, M. Melnick, C.B. Underhill, and B. Seed. 1990. CD44 is the principal cell surface receptor for hyaluronate. Cell. 61:1303.
41. Stamenkovic, I., A. Aruffo, M. Amiot, and B. Seed. 1991. The hematopoietic and epithelial forms of CD44 are distinct polypeptides with different adhesion potentials for hyaluronate-bearing cells. EMBO (Eur. Mol. Biol. Organ.) J. 10:343.
42. Spencer, D.M., T. J. Wandless, S.L. Schreiber, and G.R. Crabtree. 1993. Controlling signal transduction with synthetic ligands. Science (Wash. E>C). 262:1019.
43. Banner, D.W., A. D’Arcy, W. Janes, R. Gentz, H.-J. Schoen-feld, C. Broger, H. Loetscher, and W. Lesslauer. 1993. Crystal structure of the soluble human 55 kd TNF receptor-human TNFβ complex: implications for TNF receptor activation. Cell. 73:431.
44. Yonehara, S., A. Ishii, and M. Yonehara. 1992. Receptor system of tumor necrosis factor: cell surface Fas antigen appears to mediate only the cytolytic activity of TNF. In Tumor Necrosis Factor: Structure-Function Relationship and Clinical Application. T. Osawa, and B. Bonavida, editors. Karger, Basel. 58.
45. Beutler, B., and A. Cerami. 1989. The biology of cachectin/ TNF-a primary mediator of the best response. Annu. Rev. Immunol. 7:625.